Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07122284) titled 'Gut Microbiome-Metabolome Profiling in H. Pylori-SIBO Comorbidity' on Aug. 6.

Study Type: Observational

Primary Sponsor: Zhongshan Hospital (Xiamen), Fudan University

Condition: Gut Microbiota Metabolic Profiles Helicobacter Pylori Infection Small Intestinal Bacterial Overgrowth

Intervention: Diagnostic Test: 13C-Urea Breath Test

Recruitment Status: Not recruiting

Date of First Enrollment: January 31, 2024

Target Sample Size: 42

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07122284

Published by HT Digital Content Services with permission from Health Daily Dig...